Project Grant R44AG097237
Award Date 9/22/25
Completion Date 9/21/26
Dollars Obligated $506K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Rutland, VT 05701, USA
Similar Awards
- The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $499,943 Project Grant to Aster Labs, Inc. to design and construct an unobtrusive device to continuously monitor and analyze gait patterns in older Black adults with Alzheimer's disease and related dementias (ADRD). This innovative technology aims to provide medical professionals and caregivers with early indications of health decline in this population, which experiences higher ADRD...
- The National Institute on Aging (NIA) awarded a $780,466 Project Grant (CFDA 93.866 Aging Research) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, with a period of performance from December 15, 2024 to November 30, 2029. The goal of this project is to develop digital biomarkers using single-channel sleep electroencephalography (EEG) to monitor brain health and detect pathological aging and early neurodegenerative changes, such as those seen...
- The National Institute on Aging (NIA) awarded a $5,174,076 Cooperative Agreement to Biosensics LLC under the Aging Research federal grant program (CFDA 93.866) to develop digital health technologies for monitoring motor function in patients with Progressive Supranuclear Palsy (PSP) and Dementia with Lewy Bodies (DLB). The project will use Biosensics' patented PAMSYS and PAMSYS ULM wearable sensor platforms to comprehensively track upper and lower limb function during activities of daily...
- This Project Grant award of $129,330 from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), supports research at the Massachusetts General Hospital (MGH) to address the critical unmet need for early and accurate detection of Alzheimer's disease and related dementias (ADRD). The key products and services to be delivered under this award include: 1) deploying a multi-modal information framework that leverages decades-long in vivo and digital...
- The National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, awarded a $499,981 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Vigorous Mind, Inc. to demonstrate the feasibility of using a robot to deliver a multicomponent intervention aimed at reducing delirium in hospitalized elderly patients living with dementia. The project will develop an autonomous robot with capabilities to detect falls and fall risks, facilitate virtual...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $505,561 Project Grant to Mentia DTX Inc. to develop an AI-based empathic virtual companion to track changing health states in persons living with dementia. This two-phase solution, known as MentiaCompanion, aims to enable early detection of acute health events for people with Alzheimer's disease and related dementias, facilitating timely clinical care and reducing the likelihood of...
- The National Institute on Aging (NIA), under the Federal Aging Research program (CFDA 93.866), awarded a $245,148 project grant to Eyenexo LLC to develop an automated rodent behavior testing system for non-invasively assessing early-stage Alzheimer's disease (AD). The project aims to develop a behavior biomarker that can differentiate AD from normal aging by studying defensive behaviors triggered by looming stimuli, which are linked to early AD pathology in the midbrain region. The 2-year...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Aging awarded $865,905 under the Aging Research program (CFDA 93.866) to Careband, Inc. to develop the Appraise to Assist system. This project grant will support Careband and its partner Eperture LLC to engineer a system integrating Careband's wearable device and Eperture's tablet platform. The system aims to passively and unobtrusively monitor, empirically measure, and facilitate engagement...
- The National Institute on Aging (NIA) awarded a $467,538 Project Grant (CFDA 93.866) to Oscilloscape, Inc. (dba Oscillo Biosciences) on September 20, 2025 to develop and test an innovative, wearable digital health device called "SYNG" to help aging adults with Alzheimer's disease (AD) and mild cognitive impairment (MCI). The SYNG device aims to stimulate healthy brain rhythms via neural entrainment using a combination of music and synchronized visual brain stimulation. The key outcomes...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $114,498.00 to Temple University to investigate the construct validity of smartwatch-derived digital phenotypes against conventional neuropsychological measures and questionnaires for early detection of Alzheimer's disease and related dementias. The study will recruit a diverse sample of 90 participants aged 55 and older with either healthy cognition or mild cognitive impairment from the...